Imodium (Loperamide Hydrochloride)

Loperamide acts as a peripheral μ‑opioid receptor agonist in the myenteric plexus of the gut. By stimulating these receptors it reduces the release of acetylcholine and other excitatory neurotransmitters, which decreases smooth‑muscle contractions, slows peristalsis, and increases the time for water and electrolytes to be reabsorbed, resulting in firmer stools.

The appropriate dose of Imodium is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and clinical response. Adults typically start with an initial dose followed by additional doses as needed, while pediatric dosing follows specific guidelines. Patients should always follow the label instructions or their clinician’s advice.

Safety data for loperamide in pregnancy and lactation are limited. It is classified as a Category C medication in many regions, indicating that potential benefits must be weighed against possible risks. Women who are pregnant or breastfeeding should consult their physician before using Imodium to determine if it is appropriate for their situation.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with diphenoxylate‑atropine, another OTC antidiarrheal, loperamide has minimal central opioid activity because it does not readily cross the blood‑brain barrier, resulting in a lower risk of sedation. Both reduce stool frequency, but loperamide’s onset of action is generally faster, and it is available in a wider range of over‑the‑counter formulations.

Imodium should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture, heat, and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Imodium is taken orally, usually as a tablet or chewable tablet, with a glass of water. The dose is swallowed whole unless the product specifies a chewable form. It should be taken after the first loose stool and may be repeated according to the dosing instructions provided by a healthcare professional.

The most serious adverse events include severe constipation leading to bowel obstruction, paralytic ileus, and rare cardiac arrhythmias such as QT prolongation, especially when combined with CYP3A4 or P‑glycoprotein inhibitors. Patients should seek immediate medical attention if they experience abdominal pain, vomiting, or irregular heartbeats while using the medication.

Imodium is contraindicated in individuals with known hypersensitivity to loperamide, those with active bacterial enterocolitis, pseudomembranous colitis, or acute dysentery, and patients with a history of severe constipation or bowel obstruction. Children under a certain age may require pediatric formulations and dosing, so a healthcare professional should evaluate suitability before use.